Market Place
Sourcing Support
Emcure Pharma Adjusts Poviztra Semaglutide Injection Price
15 Apr 2026 //
EXPRESSPHARMA
Zuventus Healthcare Denies Closure Rumours, Blames Competitor
20 Jan 2026 //
PHARMABIZ
National Pharmaceutical Pricing Authority Sets Retail Prices
27 Dec 2025 //
PHARMABIZ
Emcure And MS Dhoni Launch `Winning Over Obesity` Campaign
24 Dec 2025 //
EXPRESSPHARMA
Emcure Pharma Launches Second Novo Drug For Weight Management
23 Dec 2025 //
ECONOMICTIMES
Emcure Launches Poviztra Semaglutide Injection In India
22 Dec 2025 //
EXPRESSPHARMA
Emcure Pharma Appoints Barnona Basu As Director Of Marketing
14 Dec 2025 //
INDPHARMAPOST
Emcure Pharma Reports 25% Profit Increase In Q2 With 13% Revenue
11 Nov 2025 //
ECONOMICTIMES
Emcure Partners With Novo To Increase Access To Wegovy In India
11 Nov 2025 //
BUSINESS STD
Emcure Pharma` Q1 FY26 Consolidated PAT Rises to Rs. 206.95 Cr
11 Aug 2025 //
INDPHARMAPOST
KPRDO Notes Emcure’s Reply on Stockist Appointment
17 Jul 2025 //
PHARMABIZ
Emcure, Sanofi ink Deal for Oral Anti-diabetic Products in India
17 Jul 2025 //
PRESS RELEASE
Emcure to acquire remaining stake in Zuventus Healthcare
23 Jun 2025 //
INDPHARMAPOST
KPRDO Questions Emcure’s Stockist Pick for Special Sales
16 Jun 2025 //
PHARMABIZ
Emcutix, Canada-based Mantra Pharma launch Ureaderm
14 May 2025 //
EXPRESS PHARMA
Sanofi puts insulin brand Lantus up for sale, eyes Rs 2,000 cr
15 Apr 2025 //
ECONOMICTIMES
Tillomed Labs signs £19.7M deal with Manx Healthcare
04 Apr 2025 //
EXPRESSPHARMA
Emcure Pharma share gains on foraying into daily supplements space
11 Mar 2025 //
BUSINESS STD
Emcure Pharma Q3 net profit rises 30% YoY to Rs 156 crore
06 Feb 2025 //
ECONOMICTIMES
Emcure Pharma inaugurates R&D centre in Ahmedabad
23 Jan 2025 //
PRESS RELEASE
Emcure Pharma posts Q2 FY25 consolidated PAT at Rs. 194.57 Cr
08 Nov 2024 //
INDPHARMAPOST
Emcure Pharma launches stroke awareness campaign with MS Dhoni
08 Nov 2024 //
EXPRESSPHARMA
Emcure Pharma shares climb 6% after strong growth in Q2FY25 results
08 Nov 2024 //
BUSINESS STD
Emcure Pharma Q2 PAT rises 38.2% YoY
08 Nov 2024 //
BUSINESS STD
Emcure Pharma Establishes Emcutix Biopharma for Dermatology
28 Oct 2024 //
#N/A
Emcure Sets Asia Record For Largest Heart-Shaped Structure
01 Oct 2024 //
EXPRESSPHARMA
Emcure Pharmaceuticals launches solution for menopause wellness ‘Arth’ in India
05 Sep 2024 //
INDIANPHARMAPOST
FDC ban exposes fault lines once again
03 Sep 2024 //
EXPRESS PHARMA
After 40% gains from IPO price, new listing Emcure Pharma may see further upside
26 Aug 2024 //
CNBCTV18
Emcure Pharma Promotes Public Breastfeeding For Awareness Week
02 Aug 2024 //
PHARMABIZ
Emcure Pharmaceuticals signs PPA with Sunsure Energy for solar power
26 Jul 2024 //
INDIANPHARMAPOST
Emcure Pharmaceuticals Closes At ?1362.2, Up 0.25% From Previous Day
22 Jul 2024 //
LIVEMINT
Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2
05 Jul 2024 //
ECONOMIC TIMES
Emcure Pharma fixes IPO price band at ₹960-₹1,008 a share
28 Jun 2024 //
THE HINDU
Emcure to launch the750 mg injectable variant of ferric carboxymaltose
17 May 2023 //
INDIAN PHARMA POST
Emcure seeks to toss billion-dollar lawsuit over Covid vaccine candidate
17 May 2022 //
ENDPTS
Emcure launches EmWocal campaign to raise awareness
10 May 2022 //
ET HEALTH
US firm sues Emcure for $950 million over `stealing` trade secrets
23 Mar 2022 //
TIMESOFINDIA
India Emerges as a Global Leader in Drug Manufacturing
02 Feb 2022 //
THEVOICEOFNATION
Third-wave sweeps through the country - Big pharmas brace up
20 Jan 2022 //
MIDDAY
Gennova to finish Phase 2 & 3 trials of its mRNA jab by January 2022
11 Dec 2021 //
ECONOMICTIMES
Gennova mRNA-based vaccine awaits nod
28 Sep 2021 //
FINANCIALEXPRESS
Pune-based Gennova to use SII`s Covishield vaccine as the comparator
02 Sep 2021 //
ECONOMICTIMES
Emcure Pharma files DRHP with SEBI
19 Aug 2021 //
PHARMABIZ
NPPA says it cannot calculate price of Emcure’s HIV drug as directed by DoP
09 Aug 2021 //
PHARMABIZ
Aim to take Emcure among top 5 pharma cos: MD
08 Aug 2021 //
ECONOMICTIMES
Emcure Pharma appoints four new directors
28 Jul 2021 //
EXPRESS PHARMA
DoP disposes Emcure Pharma’s review petition against price fixation on darunavir
30 Jun 2021 //
PHARMABIZ
Cipla, DRL, Emcure, Sun Pharma and Torrent to partner for trial of Molnupiravir
29 Jun 2021 //
EXPRESS PHARMA
What Trends Driving The Adalimumab Biosimilar Market? Global Key Players
19 May 2020 //
OPENPR
Aurobindo Pharma faces class action suit in US for concealing facts
08 Apr 2020 //
BUSINESS-STANDARD
What Driving Adalimumab Biosimilar Market? Top Players Alfred E. Tiefenbacher,
09 Mar 2020 //
OPENPR
DoP rejects Emcure Pharma`s review application against NPPA`s price
23 Jan 2020 //
PHARMABIZ
HC Bars Cipla, 3 others from launching generic version of Bristol-Myer`s Drug
10 Jan 2020 //
THE ECONOMIC TIMES
Big Pharma`s China growth; Pfizer`s new Upjohn HQ; Hansoh`s $1B Hong Kong IPO
31 May 2019 //
FIERCE PHARMA
New legal risks emerge for Indian pharma
20 Apr 2019 //
ECONOMICTIMES
Pharma sector gets 273 MoUs worth Rs 8,000 crore
21 Jan 2019 //
ECONOMIC TIMES
Novartis, Abbott targeted by Indian watchdog over allegations of price collusion
14 Dec 2017 //
PHARMAFILE
CCI starts probe on alleged price fixing of key anti diabetic drugs
13 Dec 2017 //
ECONOMIC TIMES
Roche, Emcure may end pact to make 2 blockbuster drugs
25 Jul 2017 //
ECONOMIC TIMES
